These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23950657)

  • 1. Potential role of gabapentin and extended-release gabapentin in the management of menopausal hot flashes.
    Yadav M; Volkar J
    Int J Gen Med; 2013; 6():657-64. PubMed ID: 23950657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.
    Cowles VE; Gordi T; Hou SY
    Clin Drug Investig; 2012 Sep; 32(9):593-601. PubMed ID: 22775354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors.
    Tran S; Hickey M; Saunders C; Ramage L; Cohen PA
    Support Care Cancer; 2021 Mar; 29(3):1183-1193. PubMed ID: 32940768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and treatment of hot flushes and menopausal mood disturbance.
    Joffe H; Soares CN; Cohen LS
    Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
    Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
    Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene effects on vasomotor and other climacteric symptoms in postmenopausal women.
    Glusman JE; Huster WJ; Paul S
    Prim Care Update Ob Gyns; 1998 Jul; 5(4):166. PubMed ID: 10838311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond frequency: who is most bothered by vasomotor symptoms?
    Thurston RC; Bromberger JT; Joffe H; Avis NE; Hess R; Crandall CJ; Chang Y; Green R; Matthews KA
    Menopause; 2008; 15(5):841-7. PubMed ID: 18521049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin for the treatment of hot flushes in menopause: a meta-analysis.
    Yoon SH; Lee JY; Lee C; Lee H; Kim SN
    Menopause; 2020 Apr; 27(4):485-493. PubMed ID: 32049930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of gabapentin in patients experiencing hot flashes.
    Brown JN; Wright BR
    Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise for vasomotor menopausal symptoms.
    Daley A; MacArthur C; Mutrie N; Stokes-Lampard H
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006108. PubMed ID: 17943886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study.
    Dam V; Dobson AJ; Onland-Moret NC; van der Schouw YT; Mishra GD
    Maturitas; 2020 Mar; 133():32-41. PubMed ID: 32005421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogens for vasomotor menopausal symptoms.
    Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review.
    Sahni S; Lobo-Romero A; Smith T
    touchREV Endocrinol; 2021 Nov; 17(2):133-137. PubMed ID: 35118459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life of women with menopausal hot flushes and night sweats.
    Ayers B; Hunter MS
    Climacteric; 2013 Apr; 16(2):235-9. PubMed ID: 22809134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.
    Biglia N; Sgandurra P; Peano E; Marenco D; Moggio G; Bounous V; Tomasi Cont N; Ponzone R; Sismondi P
    Climacteric; 2009 Aug; 12(4):310-8. PubMed ID: 19415540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premenstrual symptoms in fertile age are associated with impaired quality of life, but not hot flashes, in recently postmenopausal women.
    Hautamäki H; Haapalahti P; Savolainen-Peltonen H; Tuomikoski P; Ylikorkala O; Mikkola TS
    Menopause; 2014 Dec; 21(12):1287-91. PubMed ID: 24824645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
    Toulis KA; Tzellos T; Kouvelas D; Goulis DG
    Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.